Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WFT
1576
CALL
DELISTED
Weatherford International plc
WFT
| $9.28M | ﹤0.01% |
1,651,000
-599,900
| -27% | -$3.41M |
|
1577
Vanguard Total International Stock ETF
VXUS
$164B
| $9.23M | ﹤0.01% |
195,434
+14,413
| +8% | +$670K |
|
1578
Ionis Pharmaceuticals
IONS
$10.5B
| $9.2M | ﹤0.01% |
251,214
-146,272
| -37% | -$4.58M |
|
1579
CALL
Papa John's
PZZA
$777M
| $9.2M | ﹤0.01% |
116,700
+40,700
| +54% | +$3.04M |
|
1580
PUT
ProShares UltraShort S&P500
SDS
$398M
| $9.17M | ﹤0.01% |
5,595
-5,583
| -50% | -$9.29M |
|
|
SWFT
1581
CALL
DELISTED
Swift Transportation Company
SWFT
| $9.17M | ﹤0.01% |
426,900
+11,100
| +3% | +$211K |
|
1582
CALL
Vanguard High Dividend Yield ETF
VYM
$83.2B
| $9.15M | ﹤0.01% |
126,800
+13,100
| +12% | +$952K |
|
|
BLUE
1583
DELISTED
bluebird bio
BLUE
| $9.13M | ﹤0.01% |
10,404
+371
| +4% | +$269K |
|
1584
Coeur Mining
CDE
$22B
| $9.13M | ﹤0.01% |
771,737
+688,737
| +830% | +$9.42M |
|
|
LXK
1585
CALL
DELISTED
Lexmark Intl Inc
LXK
| $9.09M | ﹤0.01% |
227,500
+117,500
| +107% | +$4.27M |
|
|
HK
1586
CALL
DELISTED
Halcon Resources Corporation
HK
| $9.09M | ﹤0.01% |
+969,000
| New | +$11.4M |
|
|
ULTI
1587
CALL
DELISTED
Ultimate Software Group Inc
ULTI
| $9.07M | ﹤0.01% |
44,400
+18,300
| +70% | +$3.87M |
|
1588
Vail Resorts
MTN
$5.3B
| $9.05M | ﹤0.01% |
57,705
-6,607
| -10% | -$1.01M |
|
1589
Tractor Supply
TSCO
$18.3B
| $9.04M | ﹤0.01% |
671,035
+470,825
| +235% | +$7.83M |
|
1590
PUT
AstraZeneca
AZN
$257B
| $9.03M | ﹤0.01% |
137,400
-20,100
| -13% | -$1.31M |
|
1591
PUT
Exelixis
EXEL
$14B
| $9.02M | ﹤0.01% |
705,400
+586,700
| +494% | +$6.34M |
|
1592
PUT
Agios Pharmaceuticals
AGIO
$2.03B
| $9.02M | ﹤0.01% |
170,700
+17,900
| +12% | +$780K |
|
1593
PUT
Pacira BioSciences
PCRX
$1.02B
| $9.01M | ﹤0.01% |
263,400
+122,700
| +87% | +$4.81M |
|
1594
PUT
ProShares Ultra QQQ
QLD
$13.7B
| $9M | ﹤0.01% |
1,664,000
-30,400
| -2% | -$155K |
|
|
WW
1595
CALL
DELISTED
WW International
WW
| $8.96M | ﹤0.01% |
868,400
+471,200
| +119% | +$5.18M |
|
1596
CALL
SM Energy
SM
$8.53B
| $8.96M | ﹤0.01% |
232,200
-57,900
| -20% | -$1.86M |
|
1597
PUT
Henry Schein
HSIC
$10.1B
| $8.95M | ﹤0.01% |
139,995
+124,950
| +831% | +$8.29M |
|
1598
CALL
Eastman Chemical
EMN
$8.32B
| $8.93M | ﹤0.01% |
132,000
-194,800
| -60% | -$13.1M |
|
|
OIL
1599
CALL
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
| $8.91M | ﹤0.01% |
1,528,000
+627,000
| +70% | +$3.53M |
|
1600
PUT
Trinity Industries
TRN
$2.36B
| $8.89M | ﹤0.01% |
510,874
-124,177
| -20% | -$2.05M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.